Key facts about Lagevrio
What is Lagevrio?
Lagevrio is the brand name for molnupiravir and is available as an oral capsule.
What dosages is Lagevrio available in?
Lagevrio is available as a 200 mg oral capsule.
What is Lagevrio used for?
Lagevrio is an antiviral and is used to treat mild-to-moderate COVID-19 in adults who are at high risk for severe illness and aren’t able to receive other FDA-authorized treatments.
How does Lagevrio work?
Lagevrio is a nucleoside analog that treats COVID-19 by targeting the virus. It works by disrupting the process that the virus uses to make copies of itself. This means the virus won’t be able to make any more copies of itself to further spread infection.
How do I take Lagevrio?
The typical dose is 800 mg (taken as four 200 mg capsules) by mouth every 12 hours for 5 days.
Is it safe for me to take Lagevrio?
Lagevrio is a safe and effective treatment when used for FDA licensed indications. However, like all medications, they may give you unwanted side effects. You should always discuss potential side effects with your physician to ensure the medication is suitable and right for you.
Lagevrio Common Side Effects
Common side effects of Lagevrio:
- Diarrhea
Lagevrio Serious Side Effects
Serious side effects are rare with Lagevrio. Contact your healthcare provider immediately if you experience any of the following.
- Serious allergic reaction: feeling faint, dizziness, trouble breathing, swelling in the face, swollen tongue, difficulty swallowing, itchy skin, rash, hives, nausea, vomiting
Effects of other drugs, drug classes and over-the-counter products on Lagevrio
There are no major drug interactions listed for Lagevrio. However, always let your physician and pharmacist know about any other medications or supplements (including prescribed and over-the-counter medications, vitamins, and dietary or herbal supplements) that you are currently taking.
Who makes Lagevrio?
Merck & Co., Inc.
Is Lagevrio safe in pregnancy?
Based on animal data, Lagevrio may cause fetal harm when administered to pregnant individuals. It should only be used during pregnancy if the benefit to you is worth the possible risk to your baby. There is a pregnancy registry that monitors pregnancy outcomes in individuals exposed to Lagevrio during pregnancy. Encourage participation and advise patients about how they may enroll in the pregnancy registry at Covid PR registry or 1-800-616-3791.
